EMCDDA: 30 years

Description

EMCDDA: 30 years

The source data for this graphic is available in the source table on this page.

 
Date Description Label
1993 Institutional Adoption and entry into force of Council Regulation establishing the EMCDDA
1994 Cooperation First meetings of the EMCDDA Management Board, Scientific Committee and Reitox network
1995 Institutional EMCDDA opens in Lisbon under its first Director Georges Estievenart
1996 Drug situation First Annual report on the state of the drugs problem in Europe
1997 NPS Early Warning System on new synthetic drugs established
1998 NPS MBDB becomes the first new synthetic drug risk assessed
1999 NPS 4-MTA is the first new synthetic drug brought under control following risk assessment
2000 Responses Evaluation Instruments Bank launched online offering tools for evaluating drug-related interventions
2001 Cooperation Norway joins the EMCDDA
2002 Drug situation First report on the drug situation in the candidate Central and Eastern European Countries
2003 Cooperation Reitox Operating Framework adopted
2004 Cooperatoin 10 new Member States join the EMCDDA following EU enlargement
2005 Institutional Wolfgang Götz takes up post as Director
2006 Events President of the European Commission José Manuel Durão Barroso visits EMCDDA
2007 Cooperation Bulgaria and Romania join the agency following EU enlargement
2008 Responses Best practice portal launched
2009 Events Conference ‘Identifying Europe’s information needs for effective drug policy’
2010 Events First European conference on drug supply indicators
2011 Markets Trendspotter meeting on recent shocks in the European heroin market
2012 Training First European Drugs Summer School (EMCDDA–ISCTE)
2013 Markets First EU Drug Markets Report (EMCDDA–Europol)
2014 Cooperation Turkey joins the EMCDDA
2015 Events First Lisbon Addictions conference
2016 Institutional Alexis Goosdeel takes up post as Director
2017 Responses First Health and social responses to drug problems: a European guide
2018 NPS New legislation brings faster response to new drugs
2019 Responses Agency launches standardised prevention training curriculum
2020 Training EMCDDA webinars series launched
2021 Institutional Development of a new EMCDDA business model
2022 NPS 25 years of the EU Early Warning System on NPS
2023 Institutions Preparations for a new mandate paving the way for the European Union Drugs Agency
Top